logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
21/11/2025
The euro/dollar extended its decline, falling 0.3% to a two-week low of 1.1498 dollars.
Latest
1 m ago
Federal Reserve Williams: Looking ahead, it is crucial to gradually restore inflation to our long-term target of 2% in a sustainable manner. Equally important is to achieve this without unnecessary risks to our maximization of employment goal. Clear communication can limit market volatility. While the central bank must achieve the 2% inflation target, it needs to do so without causing greater harm to the labor market.
2 m ago
Google (GOOGL.US) antitrust lawsuit nearing completion, seeks to avoid splitting up its advertising business.
2 m ago
Zhongke Feice: Ha Chengshu, Chen Lu, and Gu Kainan plan to reduce their holdings by 0.0357%, 0.0178%, and 0.0027% respectively.
3 m ago
Crackdown on illegal stock recommendations, stock market rumors - Shanghai holds special action to rectify online financial information chaos summary exchange event.
4 m ago
CSPC Pharmaceutical Group Limited (003020.SZ): The application for registration and listing of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets has been accepted.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.